(Q39407374)

11 September 2017

title

Suppression of the epidermal growth factor receptor inhibits epithelial-mesenchymal transition in human pancreatic cancer PANC-1 cells (English)

1 reference

11 September 2017

1 reference

Zhi-Gang Chang

1

1 reference

11 September 2017

Jun-Min Wei

2

1 reference

11 September 2017

Chang-Fu Qin

3

1 reference

11 September 2017

Kun Hao

4

1 reference

11 September 2017

Xiao-Dong Tian

5

1 reference

11 September 2017

Kun Xie

6

1 reference

11 September 2017

Xue-Hai Xie

7

1 reference

11 September 2017

Yin-Mo Yang

8

1 reference

11 September 2017

publication date

21 January 2012

1 reference

Digestive Diseases and Sciences

11 September 2017

published in

1 reference

11 September 2017

volume

57

1 reference

11 September 2017

issue

5

1 reference

11 September 2017

page(s)

1181-1189

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-012-2036-4

11 September 2017

exact match

0 references

cites work

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2036-4

Advanced pancreatic carcinoma: current treatment and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2036-4

Cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: a multicenter phase II Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2036-4

Epidermal growth factor receptor expression in pancreatic carcinoma using tissue microarray technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2036-4

Tumour biology: herceptin acts as an anti-angiogenic cocktail.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2036-4

Clinical implications of the mechanism of epidermal growth factor receptor inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2036-4

Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2036-4

Epithelial-mesenchymal transitions in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2036-4

Epithelial-to-mesenchymal transition in pancreatic adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2036-4

Genes associated with epithelial-mesenchymal transition: possible therapeutic targets in ductal pancreatic adenocarcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2036-4

Specific cross-talk between epidermal growth factor receptor and integrin alphavbeta5 promotes carcinoma cell invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2036-4

Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2036-4

Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2036-4

E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2036-4

Pancreatic cancer cells overexpress gelsolin family-capping proteins, which contribute to their cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2036-4

Cell adhesion and signalling by cadherins and Ig-CAMs in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2036-4

The snail superfamily of zinc-finger transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2036-4

Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2036-4

Understanding resistance to EGFR inhibitors-impact on future treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2036-4

Epidermal growth factor-related peptides and their receptors in human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2036-4

Novel targets for pancreatic cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2036-4

Pancreatic cancer: molecular pathogenesis and new therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2036-4

Attenuation of proteasome-induced proteolysis in skeletal muscle by {beta}-hydroxy-{beta}-methylbutyrate in cancer-induced muscle loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2036-4

Silencing the epidermal growth factor receptor gene with RNAi may be developed as a potential therapy for non small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2036-4

Novel therapies for pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2036-4

Snail silencing effectively suppresses tumour growth and invasiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2036-4

Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2036-4

The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2036-4

Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells

21 January 2018

1 reference

12 December 2020

Cancer statistics, 1999.

1 reference

12 December 2020

Pancreatic cancer stem cells and EMT in drug resistance and metastasis.

1 reference

12 December 2020

Expression of EGF and EGFR strongly correlates with metastasis of pancreatic ductal carcinoma

1 reference

12 December 2020

Epithelial-mesenchymal transition in breast cancer progression and metastasis

1 reference

12 December 2020

Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms

1 reference

12 December 2020

Combined targeting of epidermal growth factor receptor and hedgehog signaling by gefitinib and cyclopamine cooperatively improves the cytotoxic effects of docetaxel on metastatic prostate cancer cells

1 reference

12 December 2020

Silencing of epidermal growth factor receptor suppresses hypoxia-inducible factor-2-driven VHL-/- renal cancer

1 reference

12 December 2020

Pancreatic cancer: understanding and overcoming chemoresistance

1 reference

12 December 2020

Regulation of E-cadherin/catenin complex patterns by epidermal growth factor receptor modulation in human lung cancer cells

1 reference

12 December 2020

10.1007/S10620-012-2036-4

Identifiers

DOI

1 reference

11 September 2017

1 reference